A cutting-edge mini-review published in the inaugural issue of Targetome elaborates on the value of proteome-wide ...

LET’S GET TECHNICAL. Scientists from the biotech company Life Biosciences are investigating the safety and potential side ...

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Plant regeneration represents a cornerstone of modern plant science, blending fundamental questions in developmental biology ...

Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...

With fresh focus on New Approach Methodologies (NAMs) to move away from animal models in biosciences and preclinical ...

Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University's patent licensing agreement. INCI Name: ...

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.